Literature DB >> 30187247

Viral infection and atherosclerosis.

Nima Hemmat1,2, Amin Ebadi1,2, Reza Badalzadeh3,4, Mohammad Yousef Memar2,5, Hossein Bannazadeh Baghi6,7,8.   

Abstract

Several risk factors have been described for the pathogenesis of atherosclerosis. Infectious diseases are suggested to be a causative factor, and some viruses have been studied for their relation with atherosclerotic diseases. Studies report two hypotheses, direct and indirect effects, for the role of viral infections in atherogenesis. Viruses are able to initiate atherosclerosis by two different pathways. They can exert their direct effects on atherogenesis by infecting vascular cells and then inducing inflammation in the endothelium and smooth muscle cells. Alternatively, they can also apply indirect effects by infecting non-vascular cells and inducing systemic inflammation. In this review, we consider the available data about the effects and correlations of DNA and RNA viruses on atherosclerosis.

Entities:  

Keywords:  Atherosclerosis; Inflammation; Viral infection

Mesh:

Year:  2018        PMID: 30187247     DOI: 10.1007/s10096-018-3370-z

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  91 in total

1.  The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis.

Authors:  R Horváth; J Cerný; J Benedík; J Hökl; I Jelínková; J Benedík
Journal:  J Clin Virol       Date:  2000-02       Impact factor: 3.168

2.  Herpes simplex virus infection in human arterial cells. Implications in arteriosclerosis.

Authors:  D P Hajjar; K B Pomerantz; D J Falcone; B B Weksler; A J Grant
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

3.  Atherosclerosis in apoE knockout mice infected with multiple pathogens.

Authors:  M S Burnett; C A Gaydos; G E Madico; S M Glad; B Paigen; T C Quinn; S E Epstein
Journal:  J Infect Dis       Date:  2000-12-21       Impact factor: 5.226

4.  Association of influenza vaccination and reduced risk of recurrent myocardial infarction.

Authors:  M Naghavi; Z Barlas; S Siadaty; S Naguib; M Madjid; W Casscells
Journal:  Circulation       Date:  2000-12-19       Impact factor: 29.690

5.  Can HTLV-1 infection be a potential risk factor for atherosclerosis?

Authors:  Parvaneh Layegh; Ali Shoeibi; Karim Nikkhah; Ali Ghabeli Juibary; Samaheh Raftari; Sahar Darbarpanah; Reza Boroumand; Mahmoudreza Azarpazhooh
Journal:  Intervirology       Date:  2014-10-15       Impact factor: 1.763

Review 6.  HIV-1-Associated Atherosclerosis: Unraveling the Missing Link.

Authors:  Alison Kearns; Jennifer Gordon; Tricia H Burdo; Xuebin Qin
Journal:  J Am Coll Cardiol       Date:  2017-06-27       Impact factor: 24.094

7.  Interaction of antibodies against cytomegalovirus with heat-shock protein 60 in pathogenesis of atherosclerosis.

Authors:  Caterina Bason; Roberto Corrocher; Claudio Lunardi; Patrizia Puccetti; Oliviero Olivieri; Domenico Girelli; Riccardo Navone; Ruggero Beri; Enrico Millo; Alberto Margonato; Nicola Martinelli; Antonio Puccetti
Journal:  Lancet       Date:  2003-12-13       Impact factor: 79.321

8.  Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice.

Authors:  Morteza Naghavi; Philip Wyde; Silvio Litovsky; Mohammad Madjid; Adeeba Akhtar; Sameh Naguib; Mir Said Siadaty; Susan Sanati; Ward Casscells
Journal:  Circulation       Date:  2003-02-11       Impact factor: 29.690

9.  Association between hepatitis B surface antibody seropositivity and coronary artery disease.

Authors:  Alireza Amirzadegan; Gholamreza Davoodi; Mohammad Ali Boroumand; Sirous Darabyan; Maria Raissi Dehkordi; Hamidreza Goodarzynejad
Journal:  Indian J Med Sci       Date:  2007-12

10.  Endothelial cells' activation and apoptosis induced by a subset of antibodies against human cytomegalovirus: relevance to the pathogenesis of atherosclerosis.

Authors:  Claudio Lunardi; Marzia Dolcino; Dimitri Peterlana; Caterina Bason; Riccardo Navone; Nicola Tamassia; Elisa Tinazzi; Ruggero Beri; Roberto Corrocher; Antonio Puccetti
Journal:  PLoS One       Date:  2007-05-30       Impact factor: 3.240

View more
  6 in total

1.  Association of recurrent common infections and subclinical cardiovascular disease in Mexican women.

Authors:  Priscilla Espinosa-Tamez; Martin Lajous; Carlos Cantú-Brito; Ruy Lopez-Ridaura; Adriana Monge; Elsa Yunes; Beatriz L Rodríguez; Luis Espinosa; José Sifuentes-Osornio; Andres Catzin-Kuhlmann
Journal:  PLoS One       Date:  2021-01-26       Impact factor: 3.240

Review 2.  Purinergic Signaling in Controlling Macrophage and T Cell Functions During Atherosclerosis Development.

Authors:  Davide Ferrari; Andrea la Sala; Daniela Milani; Claudio Celeghini; Fabio Casciano
Journal:  Front Immunol       Date:  2021-02-16       Impact factor: 7.561

Review 3.  Acute and Chronic Cardiovascular Manifestations of COVID-19: Role for Endotheliopathy.

Authors:  John P Cooke; John H Connor; Abhishek Jain
Journal:  Methodist Debakey Cardiovasc J       Date:  2021-12-15

4.  Growth differentiation factor-15 as a biomarker of atherosclerotic coronary plaque: Value in people living with and without HIV.

Authors:  Léna Royston; Stéphane Isnard; Nils Perrin; Liliya Sinyavskaya; Carolina Berini; John Lin; Benoit Trottier; Jean-Guy Baril; Carl Chartrand-Lefebvre; Cecile Tremblay; Madeleine Durand; Jean-Pierre Routy
Journal:  Front Cardiovasc Med       Date:  2022-08-26

Review 5.  The role of angiotensin-converting enzyme 2 in coronaviruses/influenza viruses and cardiovascular disease.

Authors:  Li Chen; Guang Hao
Journal:  Cardiovasc Res       Date:  2020-10-01       Impact factor: 10.787

6.  Induction of the Coxsackievirus and Adenovirus Receptor in Macrophages During the Formation of Atherosclerotic Plaques.

Authors:  Azadeh Nilchian; Estelle Plant; Malgorzata M Parniewska; Ana Santiago; Aránzazu Rossignoli; Josefin Skogsberg; Ulf Hedin; Ljubica Matic; Jonas Fuxe
Journal:  J Infect Dis       Date:  2020-11-13       Impact factor: 5.226

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.